Professor David Linch
David Linch is Professor of Haematology and Head of the Department of Haematology at University College London (UCL). He qualified in Medicine from Cambridge University and the Middlesex Hospital Medical School in 1975, and then undertook SHO and Registrar positions in General Medicine before entering Haematology.
He commenced his research career at UCL as a Wellcome Trust Clinical Research Fellow and then an MRC Travelling Research Fellow to the Dana Faber Cancer Institute in Boston. In 1984 he was appointed a Senior Lecturer at the Middlesex Hospital and following the first of several London Medical School mergers he was appointed to a Chair of Haematology at UCL in 1988. He took up the Headship of the Department of Haematology in 1992 and from 2004 to 2007 was the Chairman of the Division of Cancer Medicine at UCL.
His laboratory research has been in the field of myelopoiesis and myeloid leukaemias and the clinical research has been focussed on the development of high dose therapy strategies in leukaemia and lymphomas. He was the Goulstonian Lecturer of the Royal College of Physicians in 1988 and the recipient of the British Society of Haematology Gold Medal in 2006. Professor Linch has been the Chairman of the NCRI Lymphoma Clinical Studies Group and is the President of the Lymphoma Association, a national patient advisory and support organisation. He is the Chairman of the Medical Research Council Leukaemia Trials Steering Committee.
Professor Linch has served on numerous advisory bodies including the Scientific Committee and the Clinical Trials Committee of the Leukaemia Research Fund, the Medical Advisory Panel, the Cell and Molecular Panel and International Panel of the Wellcome Trust. He is currently the President of the British Society of Haematology.